Search research articles
Contact Us
Filters
Showing results (21-30 of 107) with videos related to
Page
of 11
Sort By:
Digestive Diseases and Sciences
|
December 3, 2011
Inactivation of MYO5B promotes invasion and motility in gastric cancer cells
Wenjie Dong, Xiaobing Chen, Ping Chen, et al.
Oncotarget
|
April 21, 2017
LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells
Yan Yan, Qingxia Fan, Liping Wang, et al.
Oncotargets and Therapy
|
April 25, 2017
Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer
Yan Yan, Kun Zhou, Liping Wang, et al.
International Journal of Clinical and Experimental Pathology
|
December 1, 2015
Expression of cystatin C and its effect on EC9706 cells in esophageal carcinoma
Yan Yan, Kun Zhou, Liping Wang, et al.
Technology in Cancer Research & Treatment
|
March 3, 2018
MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer
Xin Liu, Xianping Lv, Qiankun Yang, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
April 19, 2012
Clinical implication of elevated human cervical cancer oncogene-1 expression in esophageal squamous cell carcinoma
Ying Liu, Ke Li, Zhonghai Ren, et al.
Digestive Diseases and Sciences
|
January 12, 2011
miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42
Qingjiang Chen, Xiaobing Chen, Mingzhi Zhang, et al.
Magnetic Resonance in Medicine
|
October 15, 2014
Retrobulbar magnetic resonance angiography using binomial off-resonant rectangular (BORR) pulse
Yongquan Ye, Zhen Wu, Nicholas A Lewis, et al.
Oncology Research
|
March 10, 2017
miR-202 Promotes Cell Apoptosis in Esophageal Squamous Cell Carcinoma by Targeting HSF2
Xiangrui Meng, Xiaoqi Chen, Peng Lu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
January 15, 2005
Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma
Shaoliang Chen, Beilei Li, Hong Xie, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 107) with videos related to
Sort By:
Page
of 11
Digestive Diseases and Sciences
|
December 3, 2011
Inactivation of MYO5B promotes invasion and motility in gastric cancer cells
Wenjie Dong, Xiaobing Chen, Ping Chen, et al.
Oncotarget
|
April 21, 2017
LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells
Yan Yan, Qingxia Fan, Liping Wang, et al.
Oncotargets and Therapy
|
April 25, 2017
Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer
Yan Yan, Kun Zhou, Liping Wang, et al.
International Journal of Clinical and Experimental Pathology
|
December 1, 2015
Expression of cystatin C and its effect on EC9706 cells in esophageal carcinoma
Yan Yan, Kun Zhou, Liping Wang, et al.
Technology in Cancer Research & Treatment
|
March 3, 2018
MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer
Xin Liu, Xianping Lv, Qiankun Yang, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
April 19, 2012
Clinical implication of elevated human cervical cancer oncogene-1 expression in esophageal squamous cell carcinoma
Ying Liu, Ke Li, Zhonghai Ren, et al.
Digestive Diseases and Sciences
|
January 12, 2011
miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42
Qingjiang Chen, Xiaobing Chen, Mingzhi Zhang, et al.
Magnetic Resonance in Medicine
|
October 15, 2014
Retrobulbar magnetic resonance angiography using binomial off-resonant rectangular (BORR) pulse
Yongquan Ye, Zhen Wu, Nicholas A Lewis, et al.
Oncology Research
|
March 10, 2017
miR-202 Promotes Cell Apoptosis in Esophageal Squamous Cell Carcinoma by Targeting HSF2
Xiangrui Meng, Xiaoqi Chen, Peng Lu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
January 15, 2005
Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma
Shaoliang Chen, Beilei Li, Hong Xie, et al.
Page
of 11